It is generally accepted that angiotensin II plays an important role in high blood pressure (BP) development in both 2-kidney-1-clip (2K1C) Goldblatt hypertension and in partial nephrectomy (NX) model of chronic kidney disease (CKD). The contribution of sympathetic nervous system and nitric oxide to BP control in these models is less clear. Partial nephrectomy or stenosis of the renal artery was performed in adult (10-week-old) male hypertensive heterozygous Ren-2 transgenic rats (TGR) and normotensive control Hannover Sprague Dawley (HanSD) rats and in Wistar rats. One and four weeks after the surgery, basal blood pressure (BP) and acute BP responses to the consecutive blockade of renin-angiotensin (RAS), sympathetic nervous (SNS), and nitric oxide (NO) systems were determined in conscious rats. Both surgical procedures increased plasma urea, a marker of renal damage; the effect being more pronounced following partial nephrectomy in hypertensive TGR than in normotensive HanSD rats with a substantially smaller effect in Wistar rats after renal artery stenosis. We demonstrated that the renin-angiotensin system does not play so fundamental role in blood pressure maintenance during hypertension development in either CKD model. By contrast, a more important role is exerted by the sympathetic nervous system, the activity of which is increased in hypertensive TGR-NX in the developmental phase of hypertension, while in HanSD-NX or Wistar-2K1C it is postponed to the established phase. The contribution of the vasoconstrictor systems (RAS and SNS) was increased following hypertension induction. The role of NO-dependent vasodilation was unchanged in 5/6 NX HanSD and in 2K1C Wistar rats, while it gradually decreased in 5/6 NX TGR rats.

Laboratory of Experimental Hypertension Institute of Physiology of the Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

ADAMCZAK M, GROSS M-L, KRTIL J, KOCH A, TYRALLA K, AMANN K, RITZ E. Reversal of Glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol. 2003;14:2833–2842. doi: 10.1097/01.asn.0000095248.91994.d3. PubMed DOI

ANDERSON S, RENNKE HG, BRENNER BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest. 1986;77:1993–2000. doi: 10.1172/jci112528. PubMed DOI PMC

BIDANI AK, MITCHELL KD, SCHWARTZ MM, NAVAR LG, LEWIS EJ. Absence of glomerular injury or nephron loss in a normotensive rat remnant kidney model. Kidney Int. 1990;38:28–38. doi: 10.1038/ki.1990.163. PubMed DOI

BIGAZZI R, KOGOSOV E, CAMPESE VM. Altered norepinephrine turnover in the brain of rats with chronic renal failure. J Am Soc Nephrol. 1994;4:1901–1907. PubMed

BROOKS DP, SHORT BG, CYRONAK MJ, CONTINO LC, DICRISTO M, WANG YX, RUFFOLO RR. Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure. British J Pharmacol. 1993;109:581–586. doi: 10.1111/j.1476-5381.1993.tb13610.x. PubMed DOI PMC

BÜRGELOVÁ M, VAŇOURKOVÁ Z, THUMOVÁ M, DVOŘÁK P, OPOČENSKÝ M, KRAMER HJ, ŽELÍZKO M, MALÝ J, BADER M, ČERVENKA L. Impairment of the angiotensin-converting enzyme 2-angiotensin-1-7-mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension. J Hypertens. 2009;27:1988–2000. doi: 10.1097/hjh.0b013e32832f0d06. PubMed DOI

CAMPESE VM, KOGOSOV E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995a;25:878–882. doi: 10.1161/01.hyp.25.4.878. PubMed DOI

CAMPESE VM, KOGOSOV E, KOSS M. Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis. 1995b;26:861–865. doi: 10.1016/0272-6386(95)90456-5. PubMed DOI

CAMPESE VM. Pathophysiology of resistant hypertension in chronic kidney disease. Semin Nephrol. 2014;34:571–576. doi: 10.1016/j.semnephrol.2014.08.011. PubMed DOI

CERVENKA L, HORÁCEK V, VANECKOVÁ I, HUBÁCEK JA, OLIVERIO MI, COFFMAN TM, NAVAR LG. Essential role of AT1A receptor in the development of 2K1C hypertension. Hypertension. 2002;40:735–741. doi: 10.1161/01.hyp.0000036452.28493.74. PubMed DOI

ČERVENKA L, VANĚČKOVÁ I, HUSKOVÁ Z, VAŇOURKOVÁ Z, ERBANOVÁ M, THUMOVÁ M, ŠKAROUPKOVÁ P. Pivotal role of angiotensin II receptor subtype 1A in the development of two-kidney, one-clip hypertension: study in angiotensin II receptor subtype 1A knockout mice. J Hypertens. 2008;26:1379–1389. doi: 10.1097/hjh.0b013e3282fe6eaa. PubMed DOI PMC

GOLDBLATT H, KAHN JR, HANZAL RF. Studies on experimental hypertension: IX. The effect on blood pressure of constriction of the abdominal aorta above and below the site of origin of both main renal arteries. J Experim Med. 1939;69:649–674. doi: 10.1016/s0002-8703(39)90797-0. PubMed DOI PMC

GOLDBLATT H, LYNCH J, HANZAL RF, SUMMERVILLE WW. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347–379. doi: 10.1084/jem.59.3.347. PubMed DOI PMC

GRETZ N, MEISINGER E, STRAUCH M. Partial nephrectomy and chronic renal failure: The ‘mature’ rat model. Contrib Nephrol. 1988;60:46–55. doi: 10.1159/000414789. PubMed DOI

GUAN S, FOX J, MITCHELL KD, NAVAR LG. Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. Hypertension. 1992;20:763–767. doi: 10.1161/01.hyp.20.6.763. PubMed DOI

KUJAL P, VERNEROVÁ Z. 5/6 nephrectomy as an experimental model of chronic renal failure and adaptation to reduced nephron number. (In Czech) Cesk Fysiol. 2008;57:104–109. PubMed

KUJAL P, ČERTÍKOVÁ CHÁBOVÁ V, ŠKAROUPKOVÁ P, HUSKOVÁ Z, VERNEROVÁ Z, KRAMER HJ, WALKOWSKA A. Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Clin Exp Pharmacol Physiol. 2014;41:227–237. doi: 10.1111/1440-1681.12204. PubMed DOI PMC

KUJAL P, ČERTÍKOVÁ CHÁBOVÁ V, VERNEROVÁ Z, WALKOWSKA A, KOMPANOWSKA-JEZIERSKA E, SADOWSKI J, VAŇOURKOVÁ Z. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects? Clin Exper Pharmacol Physiol. 2010;37:1159–1169. doi: 10.1111/j.1440-1681.2010.05453.x. PubMed DOI

MORRISON AB. Experimentally induced chronic renal insufficiency in the rat. Lab Invest. 1962;11:321–332. PubMed

MULLINS JJ, PETERS J, GANTEN D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990;344:541–544. doi: 10.1038/344541a0. PubMed DOI

MURPHY WR, COLEMAN TG, SMITH TL, STANEK KA. Effects of graded renal artery constriction on blood pressure, renal artery pressure, and plasma renin activity in Goldblatt hypertension. Hypertension. 1984;6:68–74. doi: 10.1161/01.hyp.6.1.68. PubMed DOI

NAVAR LG, ZOU L, Von THUN A, TARNG WANG C, IMIG JD, MITCHELL KD. Unraveling the mystery of Goldblatt hypertension. News Physiol Sci. 1998;13:170–176. doi: 10.1152/physiologyonline.1998.13.4.170. PubMed DOI

OLIVEIRA-SALES, ELIZABETH B, TOWARD MA, CAMPOS RR, PATON JFR. Revealing the role of the autonomic nervous system in the development and maintenance of Goldblatt hypertension in rats. Auton Neurosc. 2014;183:23–29. doi: 10.1016/j.autneu.2014.02.001. PubMed DOI PMC

VANĚČKOVÁ I, DOBEŠOVÁ Z, KUNEŠ J, ZICHA J. The effects of repeated delivery of angiotensin II AT1 receptor antisense on distinct vasoactive systems in Ren-2 transgenic rats: young vs. adult animals. Hypertens Res. 2012a;35:761. doi: 10.1038/hr.2012.29. PubMed DOI

VANĚČKOVÁ I, KUJAL P, HUSKOVÁ Z, VAŇOURKOVÁ Z, VERNEROVÁ Z, ČERTÍKOVÁ CHÁBOVÁ V, ŠKAROUPKOVÁ P, KRAMER HJ, TESAŘ V, ČERVENKA L. Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats. Kidney Blood Press Res. 2012b;35:382–392. doi: 10.1159/000336823. PubMed DOI

WALKOWSKA A, THUMOVÁ M, ŠKAROUPKOVÁ P, HUSKOVÁ Z, VAŇOURKOVÁ Z, ČERTÍKOVÁ CHÁBOVÁ V, TESAŘ V. Intrarenal CYP-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats. J Hypertens. 2010;28:582–593. doi: 10.1097/hjh.0b013e328334dfd4. PubMed DOI PMC

ZICHA J, KRONAUER J, DUHM J. Effects of a chronic high salt intake on blood pressure and the kinetics of sodium and potassium transport in erythrocytes of young and adult subtotally nephrectomized Sprague-Dawley rats. J Hypertens. 1990;8:207–217. doi: 10.1097/00004872-199003000-00002. PubMed DOI

Gliflozins in the Treatment of Non-diabetic Experimental Cardiovascular Diseases

Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease

The organ-specific nitric oxide synthase activity in the interaction with sympathetic nerve activity: a hypothesis

Effect of iron oxide nanoparticles on vascular function and nitric oxide production in acute stress-exposed rats